Cadence Biomedical (Biotechnology, Health Care) — Funding, Investors & Signals 2026

Cadence Biomedical

Founded 2007 4 employees Series B Total: $3.05M Biotechnology, Health Care +2

Cadence Biomedical is a commercial-stage medical device company founded in 2007 and headquartered in Seattle, Washington. The company is focused on advancing neurorehabilitation in collaboration with healthcare professionals, patients, and caregivers. Their primary commercial product, Kickstart®, is a neurorehabilitation device specifically designed to expedite the recovery to walking in individuals affected by conditions such as stroke, multiple sclerosis, spinal cord injury, and other progressive neurological conditions. Kickstart is available for use in physical therapy during the initial recovery process and as a prescribed device for post-discharge use in community and home settings. In the latest funding round, Cadence Biomedical secured a $1.20M Series B investment on 25 June 2015 from investors including Frontier Angel Fund, SandHill Angels, HealthTech Capital, and BioPacific Ventures. For more information, visit www.cadencebiomedical.com.

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	••••••	4		25 Jun 2015
Series A	••••••	1		01 Jan 2013
Series A	••••••	5	•••• ••••	26 Apr 2012
Venture Round	••••••	-		20 Jan 2012
Series A	••••••	-		01 Jan 2011

Funding Stage

Amount

Investors

Lead Investors

Date

Series B

••••••

25 Jun 2015

Series A

••••••

01 Jan 2013

Series A

••••••

•••• ••••

26 Apr 2012

Venture Round

••••••

20 Jan 2012

Series A

••••••

01 Jan 2011

FAQ About Cadence Biomedical

Cadence Biomedical, a commercial-stage medical device company headquartered in Seattle, Washington, is committed to working with healthcare professionals, patients and caregivers to advance neurorehabilitation. The company’s primary commercial product, Kickstart®, is a neurorehabilitation device des...

Cadence Biomedical was founded in 2007.

Cadence Biomedical operates in the following industries: Biotechnology, Health Care, Medical Devices, Pharmaceutical.

Cadence Biomedical has approximately 4 employees.

Cadence Biomedical has completed 5 funding rounds, raising a total of $3.05M. The latest funding stage is Series B.

Top alternatives and competitors to Cadence Biomedical include Neurofenix, Real Star Rehabilitation Equipment Co., Ltd., KINESIX•XR, Evolv Rehabilitation Technologies, TRAINM Clinics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Cadence Biomedical and Neurofenix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Cadence Biomedical

General Information

Track Cadence Biomedical

Discover More

About Cadence Biomedical

Funding Rounds & Investors (5)

Cadence Biomedical Alternatives & Competitors

FAQ About Cadence Biomedical

Don't just browse. Track.